Funding for this research was provided by:
LABOKLIN GmbH & Co KG
University of Helsinki including Helsinki University Central Hospital
Received: 11 May 2022
Accepted: 30 June 2022
First Online: 20 July 2022
: Claudia Ottka and Jenni Puurunen were employees and Hannes Lohi the board director of PetBiomics Ltd.—a company providing NMR metabolomics testing for dogs, at the time of manuscript preparation. Elisabeth Müller is the managing director and Corinna Weber and Ruth Klein heads of department of LABOKLIN—a veterinary diagnostic laboratory.